REMS Events
CHI's Post-Approval Drug Safety Strategies
November 8 - 9, 2010 Philadelphia, PACambridge Healthtech Institute’s and the BioPharma Strategy Series’ fifth annual executive forum Post-Approval Drug Safety Strategies being held November 8-9, 2010 at the Crowne Plaza Philadelphia Downtown in Philadelphia, PA.
Improving products’ clinical safety will increase the industry’s fundamental value proposition to patients, healthcare providers, payors and regulators. The program will focus on pharmacovigilance program implementation and specific strategies and approaches to creating true value from a peri- and post-approval drug safety program. The approach of this conference is not to look at safety in the silos of early-phase safety or post-approval safety but to view safety holistically, across the lifecycle, especially at the transition from approval to broader use in the marketplace.
Information and registration: http://www.healthtech.com/phv?c=7747
